Shanghai Pioneer Holding Gestione
Gestione criteri di controllo 3/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Steven Yang
Amministratore delegato
CN¥655.0k
Compenso totale
| Percentuale dello stipendio del CEO | 78.8% |
| Mandato del CEO | 1.6yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 4.5yrs |
| Durata media del Consiglio di amministrazione | 2.9yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price
Jul 15
Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024
Apr 24Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024
Apr 03Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 01Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks
Mar 22Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital
Feb 26Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?
Oct 21Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024
Sep 18Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024
Sep 01Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching
Aug 09Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 14Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Mar 31Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly
Dec 15China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018
Sep 21China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward
Jun 22China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064
Apr 14China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around
Jan 16These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely
Oct 11China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year
Sep 15China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056
Sep 01China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns
Aug 26Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture
May 22We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt
Apr 25Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?
Mar 14How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?
Feb 21
Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?
Feb 03Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?
Jan 16China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet
Dec 29Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?
Dec 14China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment
Nov 29Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥164m |
| Mar 31 2024 | n/a | n/a | CN¥155m |
| Dec 31 2023 | CN¥655k | CN¥516k | CN¥146m |
| Sep 30 2023 | n/a | n/a | CN¥168m |
| Jun 30 2023 | n/a | n/a | CN¥190m |
| Mar 31 2023 | n/a | n/a | CN¥213m |
| Dec 31 2022 | CN¥752k | CN¥624k | CN¥235m |
Compensazione vs Mercato: La retribuzione totale di Steven ($USD 90.52K ) è inferiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 361.88K ).
Compensazione vs guadagni: La retribuzione di Steven è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Steven Yang (36 yo)
1.6yrs
Mandato
CN¥655,000
Compensazione
Mr. Yuewen Yang, also known as Steven, serves as Chief Executive Officer since April 2023 and serves as its Executive Director since September 16, 2022 and served as Chief Operating Officer at Shanghai Pio...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 11.8yrs | CN¥2.05m | 0.95% HK$ 23.6m | |
| CEO & Executive Director | 1.6yrs | CN¥655.00k | Nessun dato | |
| General Manager of Dental Business Division & Executive Director | 3.3yrs | CN¥717.00k | Nessun dato | |
| Chief Financial Officer | 7.9yrs | Nessun dato | Nessun dato | |
| General Manager of Investment Unit | no data | Nessun dato | Nessun dato | |
| Director of Personnel | no data | Nessun dato | Nessun dato | |
| Company Secretary | 5.7yrs | Nessun dato | Nessun dato |
4.5yrs
Durata media
49yo
Età media
Gestione esperta: Il team dirigenziale di 1345 è considerato esperto (durata media dell'incarico 4.5 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 11.8yrs | CN¥2.05m | 0.95% HK$ 23.6m | |
| CEO & Executive Director | 2.2yrs | CN¥655.00k | Nessun dato | |
| General Manager of Dental Business Division & Executive Director | 1.1yrs | CN¥717.00k | Nessun dato | |
| Independent Non-Executive Director | 2.9yrs | CN¥270.00k | Nessun dato | |
| Independent Non-Executive Director | 5.8yrs | Nessun dato | Nessun dato | |
| Non-Executive Director | 3.9yrs | CN¥184.00k | Nessun dato | |
| Independent Non-Executive Director | less than a year | Nessun dato | Nessun dato |
2.9yrs
Durata media
60yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di 1345 non è considerato esperto (durata media del mandato 2.9 anni), il che suggerisce un nuovo consiglio.